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1. INTRODUCTION 
‘Active’ phosphates, phosphonates and carba- 
mates are effective covalent inhibitors of acetyl- 
cholinesterase (AChE) [ 1,2] and therefore find use 
in research, pharmacological ,treatment and es- 
pecially in pest control. It was of interest to exam- 
ine whether other types of active reagents can also 
affect the enzyme. As carbodiimides are known to 
react with a variety of functional groups such as 
carboxylic acids, alcohols, amines, imidazoles [3] 
and have been found to react with several enzymes 
14-81, we studied the interaction of a number of 
carbodiimides with AChE. 
The water-soluble 1-(3-dimethylaminopropyl)- 
3-ethylcarbodiimide hydrochloride (DEC) and 
1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide- 
metho-p-toluenesulfonate (CMC) were found to 
be competitive inhibitors of AChE with g, = 
0.08 mM and 0.12 mM, respectively. In incubation 
with the enzyme CMC, but not DEC, causes inac- 
tivation. Analysis of the kinetics of this covalent 
inhibition suggests that binary as well as ternary 
enzyme-inhibitor complexes are formed prior to 
inactivation. Competitive inhibitors protect the 
enzyme from inactivation and several strong 
nucleophiles are capable of reactivating the cova- 
lently inhibited enzyme, suggesting that CMC 
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blocks the enzyme at the active site. Dicyclohexyl- 
carbodiimide (DCC) was devoid of either competi- 
tive or covalent inhibitory capacity. 
2. MATERIALS AND METHODS 
Acetylcholinesterase from electric eel was pur- 
chased from Worthington and Sigma. DEC, DCC 
and CMC (tig.1) were from Aldrich. Enzymic ac- 
tivity was followed pH-statically. The reaction 
mixture contained 1.2 mM acetylcholine, 0.1 M 
NaCl, 0.02 M MgC12 and 10 nM enzyme at pH 8.0, 
25°C and 0.05 N NaOH was the titrant. For mea- 
suring reversible inhibition by carbodiimide dif- 
ferent concentrations of the inhibitor were added 
to the reaction vessel containing constant concen- 
tration of substrate, enzyme was then added and 
the reaction recorded. From the Dixon plot [9] the 
inhibition constant was calculated. For measuring 
the kinetics of irreversible inhibition, different 
concentrations of carbodiimide in the 0.1-40 mM 
range were added to solution of 1 PM AChE in 
0.1 M NaCl, 0.02 M MgCl2, pH 8.0, 25°C and at 
timed intervals an aliquot of the solution was as- 
sayed for enzyme activity. The inactivation rate 
constant was obtained by plotting the log of re- 
sidual activity vs time. The kinetic parameters of 
the inhibition reaction were deduced from a Kitz- 
Wilson plot [lo]. The reactivation of CMC-inhib- 
ited enzyme was followed by incubating it in a so- 
lution containing nucleophile and at different 
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(CH,),HN+CH,C”~CH,N=C=Nc”~C”, Cl - 
DEC 
o”=C=N# 
DCC 
times an aliquot of the reaction mixture was as- 
sayed for activity. 
The enzyme concentration was determined by 
active site titration with phenothiazine-lo-carbonyl 
chloride [Ill. 
1: I I I I I I 
-Ki 0.2 0.4 0.6 0.0 1.0 
[II mM 
Fig.2. Dixon plot for the competitive inhibition of 
AChE with CMC; S1 = 0.3 mM and S2 = 0.6 mM 
acetylcholine solution; enzyme was 10 nM; the reaction 
was carried out at pH 8.0, 25°C; v0 is the initial rate in 
the case of 0.6 mM substrate and no CMC. 
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Fig.1. Formulae for DEC, DCC and CMC. 
3. RESULTS AND DISCUSSION 
Fig.%, the Dixon plot of the inhibition of AChE 
with CMC, indicates that CMC is competitive in- 
hibitor of the enzyme. The intersection of the lines 
yields Ki = 0.11 + 0.01 mM. Similar analysis of 
the interaction of AChE and DEC also yields com- 
petitive inhibition with K; = 0.08 ? 0.01 mM. The 
uncharged DCC (in 1% acetonitrile solution in 
water) did not display any inhibition. When AChE 
was followed to react with CMC at pH 8.0, 25°C 
for longer periods a progressive loss of enzymic 
activity took place with time which followed first 
order kinetics according to: 
Vi = 
WI __ = - k(E] 
dt 
where: 
k = the pseudo first-order inhibition constant 
For an irreversible inhibition which involves a 
reversible enzyme-inhibitor complex formation 
prior to the inhibition event ]eq.(2)] k is expressed 
by eq. (3) according to [IO]. 
E+I = EI 3 EI’ 
Ki 
(2) 
and 
k = ki[I]lKl+[I] (3) 
where: 
K, = the dissociation constant of EI, the enzyme- 
inhibitor complex; 
ki = the-first-order rate constant for the forma- 
tion of EI’, the irreversibly inhibited enzyme. 
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For such a case the Kitz-Wilson plot of l/k YS 
l/[I] yields a straight line with intercepts at l/ki 
and -l/& [IO]. 
For CMC inactivation of AChE plot of l/k vs 
l/II] yields a curved line, (lig.3) indicating a more 
complex mechanism than that depicted by eq. (2). 
Extrapolation of the linear right part of the curve, 
corresponding to high l/[I] values, namely low in- 
hibitor concentration, intercepts the abscissa ‘at [I] 
= 0.12 5 0.01 mM, the E1 value of the reversible 
binding step, which is equal to the competitive 
inhibition constant in Iig.2. The intercept on the 
ordinate corresponds to ki = 4.3 f 0.3 x 10-3 
min-t . However, at higher concentrations of I (low 
1 /[I] values) the line curves down and the inactiva- 
tion rate increases much faster than expected. This 
behavior can be interpreted by assuming that the 
enzyme can bind two inhibitor molecules with dif- 
ferent affinities. The high affinity has Ki = 
0.12 mM which is also the competitive inhibition 
constant and it manifests itself already at relatively 
low inhibitor concentration. The reversibly bound 
inhibitor reacts covalently with an essential group 
of the enzyme thus inhibiting it irreversibly. At 
higher concentrations of inhibitor the low affinity 
site binds another inhibitor molecule and EI2, the 
ternary complex formed, is inactivated with a 
Fig.3, Kitz-Wilson plot for inactivation of AChE with 
CMC. k is the apparent first-order constant of inactiva- 
tion. The points are experimental and the solid line was 
calculated from eq. (5) with Ki = 0.12 mM, ki = 4.3 X 
10-3 min-I, $ = 18 mM and ki = 10 x IO-3 min-1. 
The inset is expanded abscissa for the left part of 
the graph. 
larger rate constant than that of the binary com- 
plex. Such a mechanism is represented by: 
Ki K,! 
E+I s EI+ I s EI2 
ki L 
EI’ 
k; 1 
EI; 
(4) 
EI’ and EIi are the irreversibly inhibited enzyme 
forms, E, and q represent the dissociation con- 
stants of the binary and ternary enzyme-inhibitor 
complexes and k, and G are the first-order rate 
constants of irreversible inhibition of the enzyme- 
inhibitor complexes. Assuming steady state for EI 
and EI2, scheme (4) leads to the following kinetic 
equation: 
d[El 
vi= dt= 
_ [El kifc [II + kf [II2 
Kig + G [I] + [I]’ 
= - k[E] 
(5) 
Inserting Ki = 0.12 mM, ki = 4.3 x 1O-3 min-t, 
g = 18mMandki = 10 X 1O-3 min-l into eq. 
(5) results in the solid line (fig.3 and inset) which 
tits the experimental results. 
It is established that AChE can form ternary 
complexes by binding ligands to the specificity site 
and to an additional site [ 12-161, and it is likely 
that the enzyme-(CMC)z complex which is 
formed by binding ligand molecules to two sites 
undergoes enhanced covalent inhibition. A similar 
case was reported in [17] where supposed binding 
of ligand to a low affinity site greatly enhanced the 
inhibition of AChE by arsenite. It is interesting 
that DEC did not exert irreversible inhibition al- 
though it was even a slightly more effective com- 
petitive inhibitor than CMC. In [6] bovine erythro- 
cyte AChE was not inhibited by 1 mM DEC, but 
the diimide eliminated the Ca2+-induced activa- 
tion enhancement of the enzyme and rendered its 
activity to the basal Ievel. When we studied the 
effect of the uncharged DCC on the enzyme it was 
found to be devoid of any noticeable inhibition. 
The ability of the water-soluble carbodiimides to 
inhibit competitively stems from their charged am- 
monium group, (similar to a large variety of am- 
monium derivatives [11) suggesting that the inhibi- 
tor is bound to the active site of the enzyme. Also, 
addition of 10 mM tetramethylammonium chlo- 
ride, a reversible inhibitor, to a solution of enzyme 
containing 10 mM CMC decreased the inactiva- 
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tion rate by 33%, and in the presence of 100 mM of 
salt inactivation rate was decreased by 80%. 
The discrimination between CMC and DEC in 
their inactivation ability emanates most probably 
from the difference in their structure. 
Attempts were made to reactivate the covalently 
inhibited enzyme by using good nucleophiles. 
Pyridinealdoxime methiodide (2-PAM), a potent 
reactivator of phosphorylated AChE [l] failed to 
show any reactivation. However, simple nucleo- 
philes like hydroxylamine and hydrazine com- 
pletely reactivated the CMC-inhibited enzyme. 
Hydroxylamine (1 M) at pH 8 reactivated with to,s 
= 180 min and hydrazine (1 M) with t0.5 = 
100 min. 
At this point we cannot locate the enzyme 
groups attacked by CMC. However, analogy with 
other covalent inhibitions and resemblance to 
chymotrypsin inhibition by CMC [5] suggest hat 
the active site serine of AChE is modified and a 
derivatized isourea is formed: 
EOH + RtN=C=NR2 -+ EO-y=NR2 
HNRl 
y,H EOH + YC=NR2 (6) 
HAR, 
EOH denoted the active enzyme and YH is a nu- 
cleophilic reactivator. 
A less likely possibility is that another residue at 
or near the active site has been modified [ 171. 
The fact that hydroxylamine and hydrazine can 
reactivate the covalently inhibited enzyme whereas 
2-PAM cannot, suggests that the binding site in the 
enzyme is occupied by the bulky bound inhibitor 
and is not available for PAM or kindred bulky re- 
activators. However, the blocked active site is ac- 
cessible to small molecules which can react with 
the modified enzyme group and liberate the di- 
imide moiety resulting in reactivation. 
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